Literature DB >> 17854786

Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.

Simona Casini1, Hanno L Tan, Zahurul A Bhuiyan, Connie R Bezzina, Phil Barnett, Elisabetta Cerbai, Alessandro Mugelli, Arthur A M Wilde, Marieke W Veldkamp.   

Abstract

OBJECTIVE: Mutations in SCN5A, the gene encoding the alpha-subunit of the cardiac sodium channel (Na(v)1.5), have been associated with various inherited arrhythmia syndromes, including Brugada syndrome (BrS). Here, we report the functional consequences of a novel missense SCN5A mutation, G1319V, identified in a BrS patient. The G1319V mutation is located in the loop connecting transmembrane segments 4 and 5 in domain III (DIIIS4-S5), a region so far considered to be exclusively involved in fast inactivation.
METHODS: Whole-cell mutant (G1319V) and wild-type (WT) sodium currents (I(Na)) were studied in the Human Embryonic Kidney cell line (HEK-293) transfected with Na(v)1.5 alpha-subunit cDNA (WT or mutant) together with h beta(1)-subunit cDNA, using the patch-clamp technique.
RESULTS: Maximal peak I(Na) and persistent sodium current were similar in WT and channel G1319V channels. The G1319V mutation shifted the potential of half-maximal (V(1/2)) activation towards more positive potentials (+3.7 mV), thereby increasing the degree of depolarization required for activation. The V(1/2) of inactivation of G1319V channels was shifted by -6.0 mV compared to WT, resulting in a reduced channel availability. The change in the steady-state inactivation was completely due to a negative shift (-6.8 mV) of the voltage-dependence of slow inactivation, while the voltage-dependence of fast inactivation was unaffected. The fast component of recovery from inactivation of G1319V channels was slowed down. Finally, the G1319V mutation caused a two-fold increase in the propensity of the channels to enter the slow inactivated state. Reduction in I(Na) peak amplitude on repetitive depolarizations at short interpulse intervals (40 ms) was significantly more pronounced in G1319V compared to WT. Accordingly, carriers of the G1319V mutation showed marked QRS widening upon increases in heart rate during exercise testing, pointing to enhancement of slow inactivation.
CONCLUSIONS: We identified the DIIIS4-S5 linker as a new region involved in slow inactivation of Na(v)1.5. The biophysical alterations of the G1319V mutation all contribute to a reduction in I(Na), in line with the proposed mechanism underlying BrS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17854786     DOI: 10.1016/j.cardiores.2007.08.005

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  10 in total

1.  Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation.

Authors:  Brian W Jarecki; Patrick L Sheets; James O Jackson; Theodore R Cummins
Journal:  J Physiol       Date:  2008-07-03       Impact factor: 5.182

Review 2.  Genetics of sudden cardiac death.

Authors:  Alon Barsheshet; Andrew Brenyo; Arthur J Moss; Ilan Goldenberg
Journal:  Curr Cardiol Rep       Date:  2011-10       Impact factor: 2.931

Review 3.  Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.

Authors:  Carol Ann Remme
Journal:  J Physiol       Date:  2013-07-01       Impact factor: 5.182

4.  Solution structure of the NaV1.2 C-terminal EF-hand domain.

Authors:  Vesselin Z Miloushev; Joshua A Levine; Mark A Arbing; John F Hunt; Geoffrey S Pitt; Arthur G Palmer
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

5.  Ventricular tachycardia associated with lacosamide co-medication in drug-resistant epilepsy.

Authors:  Andrew C DeGiorgio; Tamara E Desso; Lance Lee; Christopher M DeGiorgio
Journal:  Epilepsy Behav Case Rep       Date:  2012-11-07

6.  Heritable arrhythmia syndromes associated with abnormal cardiac sodium channel function: ionic and non-ionic mechanisms.

Authors:  Mathilde R Rivaud; Mario Delmar; Carol Ann Remme
Journal:  Cardiovasc Res       Date:  2020-07-15       Impact factor: 10.787

7.  Characterization of the novel heterozygous SCN5A genetic variant Y739D associated with Brugada syndrome.

Authors:  Anastasia K Zaytseva; Artem M Kiselev; Alexander S Boitsov; Yulia V Fomicheva; Georgii S Pavlov; Boris S Zhorov; Anna A Kostareva
Journal:  Biochem Biophys Rep       Date:  2022-03-11

8.  Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.

Authors:  Kun-Chi Chiang; Ling-Ping Lai; Ru-Chi Shieh
Journal:  J Biomed Sci       Date:  2009-08-25       Impact factor: 8.410

9.  Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.

Authors:  Zhipeng Zeng; Jieqiong Zhou; Yuxi Hou; Xiaojing Liang; Ziguan Zhang; Xuejing Xu; Qiang Xie; Weihua Li; Zhengrong Huang
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

Review 10.  Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.

Authors:  Yingrui Li; Siegfried Lang; Ibrahim Akin; Xiaobo Zhou; Ibrahim El-Battrawy
Journal:  J Am Heart Assoc       Date:  2022-03-24       Impact factor: 6.106

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.